Ourofino SA (BSP:OFSA3)
R$ 25.28 +0.74 (+3.02%) Market Cap: 1.36 Bil Enterprise Value: 1.51 Bil PE Ratio: 5.76 PB Ratio: 1.65 GF Score: 78/100

Q2 2026 Ourofino SA Earnings Call Transcript

Aug 7, 2026 / 02:00 PM GMT
Release Date Price: R$26.42 (-4.17%)

Key Points

Positve
  • Ourofino SA (BSP:OFSA3) reported a positive second-quarter result, driven by a strategic decision to suspend certain projects and focus on higher-margin opportunities.
  • The company's animal health segment showed strong growth, with a 10% increase in revenue and a 1.1% cumulative growth rate, outperforming the overall market.
  • Ourofino SA (BSP:OFSA3) maintains a robust cash position of R$365 million, providing financial comfort and support for future investments.
  • The company is actively expanding its international presence, particularly in Latin American markets such as Colombia, Argentina, and Uruguay, with a focus on cattle and swine products.
  • Ourofino SA (BSP:OFSA3) has been recognized with awards for innovation and was named a great place to work (GPTW), highlighting its strong corporate culture and product development capabilities.
  • The company's gross margin improved by 0.08 percentage points in the quarter, reflecting better cost management and a favorable product mix.
Negative
  • Ourofino SA (BSP:OFSA3) experienced a slowdown in the cattle segment due to adverse economic conditions, which pressured overall market growth.
  • The company decided to suspend some projects to prioritize higher-value opportunities, which may limit short-term revenue diversification.
  • The competitive environment in the pharmaceutical segment for pets remains intense, requiring ongoing investment to maintain market share.
  • Ourofino SA (BSP:OFSA3) faces challenges in the swine segment, with volumes impacted by market dynamics in Latin America, particularly in Brazil.
  • The company's growth in the animal health segment was partially offset by weaker performance in other segments, leading to a more complex portfolio management situation.
  • There is uncertainty regarding the timing and impact of new product launches, as the company continues to invest in research and development without immediate returns.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OFSA3.SA - Ourofino SA
Q2 2026 Ourofino SA Earnings Call
Aug 07, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Bondia todos.

So Marcellus, si soldo rofinoso de mal. Carol Varasboas vindas.

Pronosa teleconferencia de resutado do segundo trimessis dois mi vitseis.

Obregada todos, ki sins creveli von participata teleconferencia.

Call srecognosido primi pelo clever star.

Before online, vo alternative mafere, importanti, lucetur, lagro.

Intemprafacessa a bit to the sellers on the Mercado this Mercedes mezo parsa palaba through clever. Bonjia clever.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
We do myself just on the day.

Above. Monjia
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot